Peer Review History
| Original SubmissionApril 25, 2025 |
|---|
|
Dear Dr. Noor, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== Please submit your revised manuscript by Jul 05 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Hope Onohuean, PhD Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Further research is recommended to isolate active compounds, elucidate their mechanisms of action, and assess their pharmacological safety for clinical use. 3. Please include a separate caption for each figure in your manuscript. 4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: No Reviewer #3: Partly Reviewer #4: No ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: No Reviewer #3: I Don't Know Reviewer #4: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No Reviewer #4: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes Reviewer #4: Yes ********** Reviewer #1: The topic presented in the abstract is contemporary, novel, pertinent, and impactful. The backdrop is skillfully established in the introduction, and the goals are in line with the field's current priorities. I urge the writer/writers to be more explicit in their technique with greater details and provide succinct, specific results to back up the conclusion to improve the proposal. This is a promising effort all around, however, it might need a few minor edits to make it more comprehensive and clearer. Reviewer #2: 1. If you were utilized to conduct the experiment using mice, it is obvious that your experiment is in vivo. So, I suggest the authors to remove in vivo under your title 2. Please modify the affiliation and make it complete. Try to mention the list of the authors and their respective affiliation. You have mentioned the study is conduct at United States International University but it is incomplete and include the country (Kenya) 3. Regarding the keywords, I recommended to modify it since unnecessary words are included which are not listed under the title like medicinal plants, phytochemicals, plant extracts, gastrointestinal motility,,,,,,,etc. in sum, you have missed the main words. Just try to look the title then you can find the key words. 4. Why you use “dichloromethane-Methanol” as extracting solvent. What makes it preferable from other solvents like methanol, ethanol and then like? 5. In the abstract section, your findings are not evidenced with P values. So, please include the p values in each metrics to show the level of significance 6. Why not the authors conduct castor oil induced enteropooling test which is the pillar test to evaluate the antidiarrheal activity? 7. Why not the authors present the findings which align with the method section. The authors tried to assess the onset of defecation and the total fecal output but this metrics are absent in the result section Reviewer #3: These are the reviewers’ comments for the authors; 1. As a general comment, there are some grammatical topographical errors 2. In the abstract section, specifically under the conclusion, based on the finding you have concluded that the plant has moderate antidiarrheal activity. I am confused since you need to have a standard to say mild, moderate and strong antidiarrheal activity. Please reason out for this conclusion. 3. In the conclusion part of abstract section, you have written as “While its efficacy was lower than loperamide, the extract demonstrated significant potential as a natural remedy for diarrhea”. Please omit “while” and replace with “although” 4. The authors tried to conduct phytochemical screening tests for 5 secondary metabolites. Why you left the rest like steroids, glycosides? At least it is important to include steroids under your phytochemical test because it has so many pharmacological activities. 5. Under your method section, particularly on acute toxicity study, there is a paragraph which seems the result for acute toxicity test but not appropriate place. Rather include under the result section. “The results indicated that no mortality or severe toxicity signs were observed,,,,,,,,,,.” So, I suggest removing from the method section. 6. In castor oil induced diarrheal model, the authors plan to assess to overall antidiarrheal activity but I saw from this model that you have planned to assess the “general behavior of the mice”. So, please omit it from this subsection rather include under acute toxicity incase necessary. Also, I saw a statement at the end of the 4-hour observation period, mice were carefully examined for signs of dehydration, discomfort, or toxicity). Please remove. Your plan is only to assess its overall antidiarrheal activity not observing and assessing the toxicity. 7. Under the method section, in both models, the authors tried to explain how castor oil induces diarrhea and intestinal motility. Please remove this statement as it is not necessary to narrate about its effect rather include under discussion section. 8. In the method section, to evaluate the antidiarrheal activity, you use only 2 models. Why the authors didn’t include the third model (castor oil induced enteropooling test). This is mandatory and the most pillar model while the investigators are planned to assess the antidiarrheal activity particularly to check the extracts effect on intestinal fluid accumulation. 9. Under the result section, regarding phytochemical screening test, please don’t repeat the method. The authors have already mentioned how conduct the phytochemical test. Hence, please narrate only the findings. 10. In the method section, the authors didn’t plan to conduct phytochemical tests for saponins but I have seen from the result section that the test is negative for saponins. Similarly for steroids, glycosides, anthraquinones, and reducing sugars. Why? 11. Similarly, as comment 13, in the result section, you repeat the methods. Therefore, please omit it since the authors have already written under the method section. This is my comment for acute toxicity test, castor oil induced diarrheal model, and intestinal motility test, and then like. 12. Under the result section of castor induced diarrheal model, the authors tried to show findings but not in accordance to the method. The authors were planned to assess the onset of diarrhea, total fecal output. However, I haven’t seen the results for this metrics under the result section. Why?. Please include them since as far as I know this parameters are significant when planning to assess the antidiarrheal activity 13. Here in the result section, you tried to discuss about the findings. Please only present the findings. The discussion is in the discussion part. Again, the authors are written about the onset of diarrhea and total fecal output but this metrics are absent under table 2. Why? 14. In table 3, the investigators include % inhibition of diarrhea. Please replace with % inhibition of peristaltic index (PI). 15. In the results of antimotility test, you tried to discuss about the findings. Please only present the findings 16. In the discussion section, please cite the references. I have seen some blank statements which need evidence. For instance, “Diarrhea remains a significant,,,,,,,,and pharmaceutical treatments is often limited” but not cited. 17. In the discussion section, you have also discussed about the onset of diarrhea and total fecal output which are absent under your result section. Why you discussed on this metrics? 18. In this section, the references are not cited at the proper place. Eg. Additionally, (31) reported that,,,,,,,. Please rewrite and cite at the end of the statement. 19. Under discussion section, as a general comment some statements or paragraphs are not cited. Please cite them. Reviewer #4: The current manuscript by Noor and Terefe report the effect of Croton kinondoensis (Euphorbiaceae) DCM-MEOH extract on castor oil-induced diarrhea in mice. Animals were divided into five groups of which the extract was tested over three doses. The manuscript is very traditional and lacks comprehensive experiments. The following are some of the concerns: 1. No rational for the extraction using 1: DCM-MEOH. 2. The effective dose of the plant extract used in the study is physiologically irrelevant. 3. The traditional phytochemical screening is extremely outdated. Almost all of arial parts of medicinal plants contain to some extent flavonoids/other phenolics, phytosteroids, and sugars. What's new? 4. Any plant extract at 400 mg/kg can do the same effect! ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No Reviewer #3: No Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
<p>Evaluation of the Antidiarrheal Activity of Dichloromethane-Methanol Crude Extract of the Aerial Parts of Croton kinondoensis (Euphorbiaceae) in Mice PONE-D-25-22129R1 Dear Dr. Noor, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Hope Onohuean, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewer #1: Reviewer #3: Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: No Reviewer #3: Yes ********** Reviewer #1: Thank you for the opportunity to review this manuscript. The study addresses an important topic and contributes meaningfully to the field. The overall structure is clear, and the research question is relevant and timely. I commend the authors for their effort in conducting this work and for presenting their findings in a logical manner. Reviewer #3: Actually all the comments are addressed accordingly. If possible i suggest you to conduct the 3rd model (gastroenteropoling test) to test the antisecretory effect of the extract as it is a key model while we conduct the antidiarrheal activity of a certain herbal extract. Definitely, the addition of this model will make your paper excellent. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Abraham Olutumininu Akiyode Reviewer #3: Yes: Yared Andargie Ferede ********** |
| Formally Accepted |
|
PONE-D-25-22129R1 PLOS ONE Dear Dr. Noor, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Hope Onohuean Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .